Synthesis, Potency, and in Vivo Evaluation of 2-Piperazin-1-ylquinoline Analogues as Dual Serotonin Reuptake Inhibitors and Serotonin 5-HT<sub>1A</sub>Receptor Antagonists

Dahui Zhou, Gary Stack, Jennifer R. Lo, Amedeo Failli, Deborah A. Evrard, Boyd L. Harrison, Nicole T. Hatzenbuhler, Megan Tran, Susan Croce, Soo Y. Yi,

Journal of Medicinal Chemistry · 2009 · 17 citations · 16 references

DOIFull text

Open access

Concepts

Abstract

On the basis of the previously reported clinical candidate, SSA-426 (1), a series of related 2-piperazin-1-ylquinoline derivatives 3-16 were synthesized and evaluated as dual-acting serotonin (5-HT) reuptake inhibitors and 5-HT1A receptor antagonists. In particular, compound 7 exhibits potent functional activities at both the 5-HT transporter and 5-HT1A receptor, good selectivity over the alpha1-adrenergic and dopaminergic receptors, acceptable pharmacokinetic properties, and a favorable in vivo profile.

References

16